UK Companies House feature
PHARMAPAC (U.K.) LIMITED
Cash
£447K
-42.8% vs 2023
Net assets
£8M
+2.8% vs 2023
Employees
150
+12.8% vs 2023
Profit before tax
£541K
+10.5% vs 2023
Profile
- Company number
- 03201556
- Status
- Active
- Incorporation
- 1996-05-21
- Last accounts made up
- 2024-06-30
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2024-06-30
| Metric | Trend | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £8,063,251 | £12,152,483 | |
| Operating profit | — | — | — | — | £599,547 | £546,218 | |
| Profit before tax | — | — | — | — | £490,075 | £541,292 | |
| Net profit | — | — | — | — | £107,515 | £219,317 | |
| Cash | — | — | — | — | £780,563 | £446,864 | |
| Total assets less current liabilities | — | — | — | — | £10,316,818 | £10,048,238 | |
| Net assets | — | — | — | — | £7,909,400 | £8,128,717 | |
| Equity | £5,253,168 | £2,130,652 | £5,558,065 | £10,801,885 | £7,909,400 | £8,128,717 | |
| Average employees | — | — | — | — | 133 | 150 | |
| Wages | — | — | — | — | £2,870,933 | £4,655,225 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- WHR Accountants Ltd
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors' use of the going concern basis of accounting in the financial statements is appropriate. No material uncertainties identified casting significant doubt on the company's ability to continue as a going concern for at least twelve months from authorization.”
Significant events
- “The comparative figures have been restated to incorporate the impact of hiving out the business Vector Consumer at 1st July 2023.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ELLIOTT, Geoffrey | Director | 2014-12-19 | Jan 1952 | British |
| PUGH, John James | Director | 2018-03-27 | Oct 1980 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BREWER, Suzanne | Nominee Secretary | 1996-05-21 | 1996-05-21 |
| BROWN, Clive | Secretary | 2008-06-17 | 2009-05-31 |
| ELLIOT, Geoffrey | Secretary | 2008-03-27 | 2008-06-10 |
| ROBINSON, David Albert | Secretary | 1996-05-21 | 2008-03-27 |
| SCOTT, Steven Gary | Secretary | 2010-07-01 | 2015-09-01 |
| BREWER, Kevin, Dr | Nominee Director | 1996-05-21 | 1996-05-21 |
| ELLIOT, Geoffrey | Director | 2008-03-27 | 2008-06-10 |
| ELLIOTT, Keith | Director | 2014-12-19 | 2016-06-01 |
| ELLIOTT, Mark | Director | 2014-12-19 | 2016-06-01 |
| ENNIS, Harold Alexander, Dr | Director | 2008-03-27 | 2008-06-10 |
| ENNIS, Mark | Director | 2008-03-27 | 2008-06-10 |
| PENROSE, Stephen Patrick | Director | 1997-01-08 | 2008-03-27 |
| ROBINSON, David Albert | Director | 1996-05-21 | 2008-03-27 |
| ROBINSON, Ian Paul | Director | 2006-03-01 | 2017-03-10 |
| SAMPSON, Andrew Michael | Director | 1996-05-21 | 2020-03-10 |
| WARD, Andrew John | Director | 2002-06-12 | 2014-12-19 |
| WHITE, Paul John | Director | 1997-01-08 | 2000-06-26 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Pharmapac Holdings Limited | Corporate entity | Shares 75–100% | 2025-12-01 | Active |
| Mr Robert Geoffrey Elliott | Individual | Significant influence | 2016-04-09 | Ceased 2025-12-01 |
Filing timeline
Last 20 of 123 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-05-07 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-12-23 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-12-23 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-08-08 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-06-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-02-25 | AA | accounts | accounts with accounts type full |
| 2024-05-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-03-27 | AA | accounts | accounts with accounts type full |
| 2023-05-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-03-29 | AA | accounts | accounts with accounts type full |
| 2022-06-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-05-31 | AA | accounts | accounts with accounts type full |
| 2021-07-07 | AA | accounts | accounts with accounts type full |
| 2021-06-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-05-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-04-17 | TM01 | officers | termination director company with name termination date |
| 2020-03-30 | AA | accounts | accounts with accounts type full |
| 2019-05-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-03-20 | AA | accounts | accounts with accounts type full |
| 2018-05-22 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ (private-firm) · reference 2024-06-30
4.25
SAFE
Altman Z″
- Working capital / Total assets 0.330 × 6.56 = +2.17
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.042 × 6.72 = +0.29
- Book equity / Total liabilities 1.711 × 1.05 = +1.80
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory